Interaction between the aryl hydrocarbon receptor and retinoic acid pathways increases matrix metalloproteinase-1 expression in keratinocytes

被引:71
作者
Murphy, KA [1 ]
Villano, CM [1 ]
Dorn, R [1 ]
White, LA [1 ]
机构
[1] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08901 USA
关键词
D O I
10.1074/jbc.M402168200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Exposure to the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) results in a variety of pathological lesions in humans via activation of the aryl hydrocarbon receptor (AhR) pathway. It has become apparent that this pathway interacts with a variety of signaling pathways that are believed to be involved in mediating TCDD/AhR biological effects. Our hypothesis is that TCDD mediates these pathological lesions by directly altering the expression of genes involved in matrix deposition and remodeling and that the retinoic acid signaling pathway is involved in modulating TCDD-induced effects. Therefore, we examined the effect of TCDD and all-trans retinoic acid (atRA) on the expression of matrix metalloproteinase-1 (MMP-1, interstitial collagenase), one of the proteolytic enzymes that degrade type I collagen, in normal human keratinocytes. The data show that TCDD exposure results in increased MMP-1 expression in keratinocytes that is further enhanced by co-treatment with all-trans retinoic acid. TCDD-induced expression of MMP-1 appears to be mediated through two AP-1 elements in the proximal promoter of the MMP-1 gene. However, retinoic acid-mediated induction of keratinocyte MMP-1 is a result of both promoter activation and increased mRNA stability. These findings are the first to demonstrate TCDD-induced expression of MMP-1 and to demonstrate interactions between the TCDD/AhR and retinoic acid pathways on MMP-1 expression.
引用
收藏
页码:25284 / 25293
页数:10
相关论文
共 57 条
[1]   TCDD-INDUCED ALTERED EXPRESSION OF GROWTH-FACTORS MAY HAVE A ROLE IN PRODUCING CLEFT-PALATE AND ENHANCING THE INCIDENCE OF CLEFTS AFTER COADMINISTRATION OF RETINOIC ACID AND TCDD [J].
ABBOTT, BD ;
BIRNBAUM, LS .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1990, 106 (03) :418-432
[2]   RT-PCR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone [J].
Abbott, BD ;
Schmid, JE ;
Brown, JG ;
Wood, CR ;
White, RD ;
Buckalew, AR ;
Held, GA .
TOXICOLOGICAL SCIENCES, 1999, 47 (01) :76-85
[3]   THE AP-1 SEQUENCE IS NECESSARY BUT NOT SUFFICIENT FOR PHORBOL INDUCTION OF COLLAGENASE IN FIBROBLASTS [J].
AUBLE, DT ;
BRINCKERHOFF, CE .
BIOCHEMISTRY, 1991, 30 (18) :4629-4635
[4]   Transcriptional repression of the human collagenase-1 (MMP-1) gene in MDA231 breast cancer cells by all-trans-retinoic acid requires distal regions of the promoter [J].
Benbow, U ;
Rutter, JL ;
Lowrey, CH ;
Brinckerhoff, CE .
BRITISH JOURNAL OF CANCER, 1999, 79 (02) :221-228
[5]   Biological assay for activity and molecular mechanism of retinoids in cervical tumor cells [J].
Benbrook, DM ;
Lu, SN ;
Flanagan, C ;
ShenGunther, J ;
Angros, LH ;
Lightfoot, SA .
GYNECOLOGIC ONCOLOGY, 1997, 66 (01) :114-121
[6]   XENOESTROGENS ALTER MAMMARY-GLAND DIFFERENTIATION AND CELL-PROLIFERATION IN THE RAT [J].
BROWN, NM ;
LAMARTINIERE, CA .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1995, 103 (7-8) :708-713
[7]   Characterization of the Ah receptor-associated protein, ARA9 [J].
Carver, LA ;
LaPres, JJ ;
Jain, S ;
Dunham, EE ;
Bradfield, CA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (50) :33580-33587
[8]   A decade of molecular biology of retinoic acid receptors [J].
Chambon, P .
FASEB JOURNAL, 1996, 10 (09) :940-954
[9]   Constitutive activation of the aromatic hydrocarbon receptor [J].
Chang, CY ;
Puga, A .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (01) :525-535
[10]   Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 [J].
Chen, HW ;
Lin, RJ ;
Schiltz, RL ;
Chakravarti, D ;
Nash, A ;
Nagy, L ;
Privalsky, ML ;
Nakatani, Y ;
Evans, RM .
CELL, 1997, 90 (03) :569-580